• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬皮病的光疗:生物学原理、结果及前景。

Phototherapy for scleroderma: biologic rationale, results, and promise.

作者信息

Fisher Gary J, Kang Sewon

机构信息

Department of Dermatology, University of Michigan, Ann Arbor, 48109-0609, USA.

出版信息

Curr Opin Rheumatol. 2002 Nov;14(6):723-6. doi: 10.1097/00002281-200211000-00016.

DOI:10.1097/00002281-200211000-00016
PMID:12410098
Abstract

Scleroderma is a chronic disease of connective tissue characterized by deposition of large amounts of collagen. Localized scleroderma affects only the skin, whereas systemic disease, systemic sclerosis, may affect the lungs, gastrointestinal tract, kidneys, and heart in addition to the skin. Although the various forms of localized scleroderma are not life threatening, they result in considerable morbidity owing to joint contracture, loss of flexibility, and disfigurement. Although many different treatments have been attempted, until now none has proven to be effective. Accumulating evidence indicates that UVA irradiation offers a genuine opportunity to ameliorate localized scleroderma and the cutaneous manifestations of systemic sclerosis.

摘要

硬皮病是一种结缔组织的慢性疾病,其特征是大量胶原蛋白沉积。局限性硬皮病仅累及皮肤,而系统性疾病,即系统性硬化症,除皮肤外还可能影响肺、胃肠道、肾脏和心脏。尽管各种形式的局限性硬皮病不会危及生命,但由于关节挛缩、灵活性丧失和毁容,它们会导致相当大的发病率。尽管已经尝试了许多不同的治疗方法,但到目前为止,没有一种方法被证明是有效的。越来越多的证据表明,紫外线A照射为改善局限性硬皮病和系统性硬化症的皮肤表现提供了一个真正的机会。

相似文献

1
Phototherapy for scleroderma: biologic rationale, results, and promise.硬皮病的光疗:生物学原理、结果及前景。
Curr Opin Rheumatol. 2002 Nov;14(6):723-6. doi: 10.1097/00002281-200211000-00016.
2
Phototherapy for sclerosing skin conditions.用于硬化性皮肤病的光疗
Clin Dermatol. 2016 Sep-Oct;34(5):614-22. doi: 10.1016/j.clindermatol.2016.05.012. Epub 2016 May 20.
3
UVA therapy for scleroderma.用于硬皮病的紫外线A疗法
J Am Acad Dermatol. 1999 May;40(5 Pt 1):787-8. doi: 10.1016/s0190-9622(99)70172-6.
4
UVA1 irradiation attenuates collagen production via Ficz/AhR/MAPK signaling activation in scleroderma.UVA1 照射通过 Ficz/AhR/MAPK 信号通路激活减轻硬皮病中的胶原产生。
Int Immunopharmacol. 2023 Mar;116:109764. doi: 10.1016/j.intimp.2023.109764. Epub 2023 Jan 25.
5
Period of remission after treatment with UVA-1 in sclerodermic skin diseases.硬皮病性皮肤病经UVA - 1治疗后的缓解期。
J Eur Acad Dermatol Venereol. 2008 Jul;22(7):839-44. doi: 10.1111/j.1468-3083.2007.02576.x. Epub 2008 Apr 30.
6
Ultraviolet phototherapy for cutaneous diseases: a concise review.用于皮肤病的紫外线光疗:简要综述
Oral Dis. 2016 May;22(4):253-9. doi: 10.1111/odi.12366. Epub 2015 Oct 13.
7
Ultraviolet A1 phototherapy for the treatment of localized scleroderma.紫外线A1光疗治疗局限性硬皮病
J Dermatol. 2020 Jul;47(7):792-795. doi: 10.1111/1346-8138.15368. Epub 2020 May 8.
8
UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review.UVA/UVA1光疗及补骨脂素紫外线A光化学疗法治疗结缔组织病及相关病症:一项基于研究的综述
BMC Dermatol. 2004 Sep 20;4(1):11. doi: 10.1186/1471-5945-4-11.
9
Clinical and laboratory characterization of patients with localized scleroderma and response to UVA-1 phototherapy: In vivo and in vitro skin models.局限性硬皮病患者的临床和实验室特征及 UVA-1 光疗的反应:体内和体外皮肤模型。
Photodermatol Photoimmunol Photomed. 2022 Nov;38(6):531-540. doi: 10.1111/phpp.12786. Epub 2022 Apr 3.
10
Biological effects of a new ultraviolet A prototype based on light-emitting diodes on the treatment of localized scleroderma.基于发光二极管的新型紫外线 A 原型在局部硬皮病治疗中的生物学效应。
Exp Dermatol. 2020 Dec;29(12):1199-1208. doi: 10.1111/exd.14135. Epub 2020 Jul 20.

引用本文的文献

1
Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma: a clinical and immunohistochemical randomized controlled study.分次二氧化碳激光与低剂量UVA-1光疗治疗局限性硬皮病:一项临床和免疫组织化学随机对照研究。
Lasers Med Sci. 2016 Nov;31(8):1707-1715. doi: 10.1007/s10103-016-2041-5. Epub 2016 Aug 10.
2
Dermal damage promoted by repeated low-level UV-A1 exposure despite tanning response in human skin.尽管人类皮肤有晒黑反应,但反复低水平的长波紫外线 A1 照射仍会导致皮肤损伤。
JAMA Dermatol. 2014 Apr;150(4):401-6. doi: 10.1001/jamadermatol.2013.8417.
3
The use of streptolysin o for the treatment of scars, adhesions and fibrosis: initial investigations using murine models of scleroderma.
用链球菌溶血素O治疗瘢痕、粘连和纤维化:使用硬皮病小鼠模型的初步研究。
Nonlinearity Biol Toxicol Med. 2004 Apr;2(2):67-87. doi: 10.1080/15401420490464295.
4
Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy.色素沉着增加对人皮肤抗纤维化紫外线A1光疗反应的影响。
Arch Dermatol. 2008 Jul;144(7):851-8. doi: 10.1001/archderm.144.7.851.
5
Systemic and localized scleroderma in children: current and future treatment options.儿童系统性和局限性硬皮病:当前及未来的治疗选择
Paediatr Drugs. 2006;8(2):85-97. doi: 10.2165/00148581-200608020-00002.
6
UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review.UVA/UVA1光疗及补骨脂素紫外线A光化学疗法治疗结缔组织病及相关病症:一项基于研究的综述
BMC Dermatol. 2004 Sep 20;4(1):11. doi: 10.1186/1471-5945-4-11.